ArticleJCI insight2021

Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner.

Sara L Jepsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.